4.6 Article

Aphrodisiac Performance of Bioactive Compounds from Mimosa pudica Linn.: In Silico Molecular Docking and Dynamics Simulation Approach

Journal

MOLECULES
Volume 27, Issue 12, Pages -

Publisher

MDPI
DOI: 10.3390/molecules27123799

Keywords

bioactive molecules; Mimosa pudica Linn; molecular docking; molecular dynamics simulation; penile erection

Funding

  1. National Science Centre, Poland [2019/35/B/NZ8/04523]
  2. [BT/PR36633/TRM/120/277/2020]

Ask authors/readers for more resources

This study aimed to predict highly effective molecules from Mimosa pudica Linn. for treating male erectile dysfunction through molecular docking and dynamics simulation. Four bioactive molecules showed stronger binding affinities with the target enzyme compared to the standard inhibitor, suggesting their potential as potent PDE5 inhibitors for the treatment of ED.
Plants and their derived molecules have been traditionally used to manage numerous pathological complications, including male erectile dysfunction (ED). Mimosa pudica Linn. commonly referred to as the touch-me-not plant, and its extract are important sources of new lead molecules in drug discovery research. The main goal of this study was to predict highly effective molecules from M. pudica Linn. for reaching and maintaining penile erection before and during sexual intercourse through in silico molecular docking and dynamics simulation tools. A total of 28 bioactive molecules were identified from this target plant through public repositories, and their chemical structures were drawn using Chemsketch software. Graph theoretical network principles were applied to identify the ideal target (phosphodiesterase type 5) and rebuild the network to visualize the responsible signaling genes, proteins, and enzymes. The 28 identified bioactive molecules were docked against the phosphodiesterase type 5 (PDE5) enzyme and compared with the standard PDE5 inhibitor (sildenafil). Pharmacokinetics (ADME), toxicity, and several physicochemical properties of bioactive molecules were assessed to confirm their drug-likeness property. Molecular dynamics (MD) simulation modeling was performed to investigate the stability of PDE5-ligand complexes. Four bioactive molecules (Bufadienolide (-12.30 kcal mol(-1)), Stigmasterol (-11.40 kcal mol(-1)), Isovitexin (-11.20 kcal mol(-1)), and Apigetrin (-11.20 kcal mol(-1))) showed the top binding affinities with the PDE5 enzyme, much more powerful than the standard PDE5 inhibitor (-9.80 kcal mol(-1)). The four top binding bioactive molecules were further validated for a stable binding affinity with the PDE5 enzyme and conformation during the MD simulation period as compared to the apoprotein and standard PDE5 inhibitor complexes. Further, the four top binding bioactive molecules demonstrated significant drug-likeness characteristics with lower toxicity profiles. According to the findings, the four top binding molecules may be used as potent and safe PDE5 inhibitors and could potentially be used in the treatment of ED.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available